首页工具

登录

搜索结果

Search Results for " spleen tyrosine kinase "

36

抑制剂 & 化合物

1

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T4209	TAK-659 hydrochloride TAK-659	VEGFR; FLT; Tyrosine Kinases; JAK; Syk	Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
	TAK-659 hydrochloride (TAK-659) 是可逆的、高效的、选择性的、口服有效的 SYK/FLT3 双抑制剂，对 SYK 和 FLT3 作用的IC50值分别为 3.2 nM、4.6 nM。它能诱导肿瘤细胞死亡，却不作用于非肿瘤细胞，对慢性淋巴细胞白血病具有潜在的研究价值。
T39437	Cevidoplenib dimesylate	Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	Cevidoplenib dimesylate 是一种脾酪氨酸激酶 (Syk) 抑制剂，具有抗炎和免疫调节特性。
T16776	RO9021	Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	RO9021 是口服具有活力的，ATP 竞争性的 SYK 抑制剂，其 IC50=5.6 nM。
T14331	Gusacitinib ASN-002	JAK; Syk	Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
	Gusacitinib (ASN-002) 是一种有效的 SYK 激酶和JAK 激酶的双抑制剂，IC50值为 5 到 46 nM 之间，具有抗癌活性。
T6594	MNS	Syk; Src; p97	Angiogenesis; Tyrosine Kinase/Adaptors; Ubiquitination
	MNS 是一种酪氨酸激酶抑制剂和广谱抗血小板药物，是一种 β-硝基苯乙烯衍生物。它完全抑制 U46619 (IC50:2.1 μM)、ADP (IC50:4.1 μM)、花生四烯酸 (IC50:5.8 μM)、胶原 (IC50:7.0 μM)和凝血酶 (IC50:12.7 μM)诱导的血小板聚集，并抑制 Src (IC50:27.3 μM)、Syk (IC50:2.8 μM) 和 FAK (IC50:97.6 μM)。
T11824LL	Lanraplenib GS-9876	Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	Lanraplenib (GS-9876) 是高效的、选择性的、口服具有活力的 SYK 抑制剂 (IC50=9.5 nM) ，能够用于炎症性疾病的研究。它通过糖蛋白 VI (GPVI) 受体抑制血小板中的 SYK 活性，而不会延长猴子或人类的出血时间 (BT)。
T6101	Entospletinib GS-9973	Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	Entospletinib (GS-9973) 是选择性的Syk 抑制剂，其IC50=7.7 nM。
T6115	Fostamatinib R788,福他替尼	FLT; Syk; Monoamine Transporter; Adenosine Receptor	Angiogenesis; GPCR/G Protein; Membrane transporter/Ion channel; Neuroscience; Tyrosine Kinase/Adaptors
	Fostamatinib (R788) 是一种口服具有活力的 R406 前药。其中R406 是具有口服活性的，有效的，ATP 竞争性的Syk/FLT3抑制剂(Ki:30 nM，IC50:41 nM)，也能够抑制 Lyn (IC50:63 nM) 和 Lck (IC50:37 nM)。
T6174	R406 R-406 besylate	Apoptosis; FLT; Syk	Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
	R406 (R-406 besylate) 是一种具有口服活性的 ATP 竞争性 Syk/FLT3抑制剂，Ki 为 30 nM。它有效抑制 Syk 激酶活性，IC50为 41 nM。它还抑制 Lyn 和 Lck，IC50值分别为 63 nM 和 37 nM。它可减轻免疫复合物介导的炎症。
T2467	R406 free base R406 (free base)	Apoptosis; FLT; Syk	Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
	R406 free base (R406(free base)) 是一种具有口服活性的，ATP 竞争性的Syk/FLT3抑制剂，Ki 为 30 nM。它有效抑制 Syk 激酶活性，IC50为 41 nM，可减轻免疫复合物介导的炎症。它还抑制 Lyn 和 Lck，IC50分别为 63 nM 和 37 nM。
T4348	Syk Inhibitor II	5-HT Receptor; Syk	Angiogenesis; GPCR/G Protein; Neuroscience; Tyrosine Kinase/Adaptors
	Syk Inhibitor II 是一种可渗透细胞、具有 ATP 竞争性的嘧啶-甲酰胺化合物，可选择性且可逆地抑制 Syk，IC50为 41 nM。
T2487	Cerdulatinib PRT2070,赛度替尼,PRT062070	Tyrosine Kinases; JAK; Syk	Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
	Cerdulatinib (PRT2070) 是一种选择性 Tyk2抑制剂，IC50为 0.5 nM。它是 JAK 和 SYK 的双抑制剂，抑制JAK1、2、3 和SYK 的IC50分别为12、6、8 和 32。
T3185	R112 (E)-Elafibranor	Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	R112 ((E)-Elafibranor) 是ATP 竞争性的 Syk 激酶抑制剂，它能够抑制Syk 激酶活性，Ki=6 nM，IC50=226 nM。
T6957	PRT-060318 P142-76,PRT318,PRT-060318 2HCl	Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	PRT-060318 (P142-76) 是一种新颖的、选择性的酪氨酸激酶 (Syk) 抑制剂，其IC50=4 nM。
T2605	Fostamatinib Disodium Tamatinib Fosdium,福他替尼二钠盐,R788(Disodium),R788 Disodium,R788 (Fostamatinib) Disodium	FLT; Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	Fostamatinib Disodium (R788 Disodium) 是一种口服具有活力的 R406 前药。其中R406 是具有口服活性的，有效的，ATP 竞争性的Syk/FLT3抑制剂(Ki:30 nM，IC50:41 nM)，也能够抑制 Lyn (IC50:63 nM) 和 Lck (IC50:37 nM)。
T6776	BAY 61-3606 dihydrochloride BAY 61-3606,BAY-61-3606 dihydrochloride	Apoptosis; Syk	Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
	BAY 61-3606 dihydrochloride (BAY 61-3606) 是一种口服有效的，ATP 竞争性的，可逆的选择性Syk 抑制剂。它降低神经母细胞瘤细胞中的 ERK1/2 和 Akt 磷酸化，也降低 K-rn 细胞裂解物中 Syk 磷酸化。它作用于乳腺癌细胞，通过下调 Mcl-1 促进 TRAIL 诱导的细胞凋亡。
T2696	PRT062607 hydrochloride PRT062607 (P505-15, BIIB057) HCl,P505-15 Hydrochloride	MLK; Syk; Src	Angiogenesis; MAPK; Tyrosine Kinase/Adaptors
	PRT062607 hydrochloride (P505-15 Hydrochloride) 是纯化的 Syk 抑制剂，IC50=1-2 nM。
T4263	BAY 61-3606 2-[[7-(3,4-二甲氧基苯基)咪唑并[1,2-C]嘧啶-5-基]氨基]-3-吡啶甲酰胺,Syk inhibitor IV	Apoptosis; Syk	Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
	BAY 61-3606 (Syk inhibitor IV) 是一种具有口服活性的，ATP 竞争性的可逆选择性Syk 抑制剂。它作用于乳腺癌细胞，通过下调 Mcl-1 促进 TRAIL 诱导的细胞凋亡。它降低神经母细胞瘤细胞中的 ERK1/2 和 Akt 磷酸化，也降低 K-rn 细胞裂解物中 Syk 磷酸化。
T6104	Cerdulatinib hydrochloride Cerdulatinib,PRT2070,PRT062070 hydrochloride,PRT062070,PRT2070 hydrochloride	MLK; c-Fms; Tyrosine Kinases; Hippo pathway; JAK; Syk	Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; Stem Cells; Tyrosine Kinase/Adaptors
	Cerdulatinib hydrochloride (PRT2070 hydrochloride) 是一种选择性可逆，具有口服活性、 ATP 竞争性的 SYK 和 JAK 的双重抑制剂，抑制 JAK1、2、3、SYK 和 Tyk2的 IC50值分别为12、6、8、32 和 0.5 nM。它可用于研究自身免疫性疾病和B 细胞恶性肿瘤。
T28281	OXSI-2 OXSI 2,Syk Inhibitor	Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	OXSI-2 (Syk Inhibitor) 是 Syk 的抑制剂，EC50 为 313 nM，IC50 为 14 nM。 OXSI-2 完全抑制适配器蛋白 LAT Y191 磷酸化和 Syk 介导的血小板聚集。
T9789	Cevidoplenib dimesylate hydrochloride	Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	Cevidoplenib dimesylate hydrochloride 是一种脾酪氨酸激酶 (Syk) 抑制剂，具有潜在的免疫调节和抗炎特性。
T9659	LCB 03-0110 3-(2-(3-(Morpholinomethyl)phenyl)thieno[3,2-b]pyridin-7-ylamino)phenol	Discoidin Domain Receptor (DDR)	Tyrosine Kinase/Adaptors
	LCB 03-0110 (3-(2-(3-(Morpholinomethyl)phenyl)thieno[3,2-b]pyridin-7-ylamino)phenol) 是一种盘状结构域受体家族酪氨酸激酶的强效抑制剂，可强烈抑制多种酪氨酸激酶，包括 c-Src 家族、脾酪氨酸激酶、布鲁顿酪氨酸激酶和血管内皮生长因子受体 2，它们对免疫很重要细胞信号传导和炎症反应。
T24584	P505-15 Acetate PRT 062607 Acetate,P505 15 Acetate,PRT-062607 Acetate,PRT062607 Acetate,P50515 Acetate	Tyrosinase	Proteases/Proteasome
	P505-15 Acetate 是脾脏酪氨酸激酶的选择性抑制剂，通过抑制白细胞免疫功能和炎症起作用，导致关节炎评分降低和组织学损伤减轻。
T4391	Syk Inhibitor II dihydrochloride Syk Inhibitor II (hydrochloride)	Others; Tyrosine Kinases; Syk; PKC; BTK	Angiogenesis; Chromatin/Epigenetic; Cytoskeletal Signaling; Others; Tyrosine Kinase/Adaptors
	Syk Inhibitor II (hydrochloride) 是一种非受体酪氨酸激酶，磷酸化后，它与 FcRγ 链的基于免疫受体酪氨酸的激活基序结合，并介导与血小板功能和炎症相关的下游信号传导。 Syk inhibitor II 是一种可渗透细胞的嘧啶-甲酰胺化合物，以 ATP 竞争性方式选择性和可逆地阻断 Syk (IC50 = 41 nM)。它对 PKCε、PKCβII、ZAP-70、Btk 和 Itk 的效力要低得多（IC50s 分别为5.1、11、11.2、15.5 和 22.6 μM）。
T9543	Syk Inhibitor II hydrochloride	Others	Others
	Syk Inhibitor II hydrochloride 信号传导的影响在狼疮中可能很突出。
T70931	SYK-IN-II
	SYK-IN-II is an inhibitor of the spleen tyrosine kinase (STK).
T21062	TAK-659 TAK 659,TAK659
	TAK-659 is a spleen tyrosine kinase (SYK) inhibitor.
T37602	GSK 143
	Spleen tyrosine kinase (Syk) inhibitor (pIC50 = 7.5). Also inhibits phosphorylated Erk (pIC50 = 7.1). Decreases cell number and viability in chronic lymphocytic leukemia (CCL) cell lines. Liddle et al (2011) Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor. Bioorg.Med.Chem.Lett. 21 6188 PMID:21903390 \|Varghese et al (2018) Highly selective SYK inhibitor, GSK143, abrogates survival signals in chronic lymphocytic leukaemia. Br.J.Haematol 182 9...
T70994	TAK-659 HCl
	TAK-659 is an inhibitor of spleen tyrosine kinase (syk), with potential anti-inflammatory, immunomodulating, and antineoplastic activities. Spleen tyrosine kinase inhibitor TAK-659 may inhibit the activity of syk, which abrogates downstream B-cell receptor (BCR) signaling and leads to an inhibition of B-cell activation, chemotaxis, adhesion and proliferation. Note: TAK-659 free base is less stable. This product is supplied as dihydrochloride form.
T78943	Syk-IN-7	Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	Syk-IN-7（化合物17）是一类特定的酪氨酸激酶（SYK）抑制剂。
T70930	GSK SYK inhibitor
	The immunoregulator spleen tyrosine kinase (SYK) is upregulated in cutaneous lupus erythematosus (CLE). This double-blind, multicentre, Phase Ib study evaluated the safety, tolerability, pharmacokinetics, pharmacodynamics and clinical efficacy of the selective SYK inhibitor GSK2646264 in active CLE lesions
T39874	GSK143 dihydrochloride
	GSK143 dihydrochloride is a highly selective, orally active inhibitor of spleen tyrosine kinase (SYK), exhibiting a pIC 50 value of 7.5. It effectively inhibits phosphorylated Erk (pErk) with a pIC 50 value of 7.1. The compound demonstrates anti-inflammatory properties and hinders the recruitment of immune cells in the intestinal muscularis of mice.
T61527	GSK2646264
	GSK2646264 (Compound 44) is a highly effective and specific inhibitor of spleen tyrosine kinase (SYK) with a pIC50 of 7.1. In addition to targeting SYK, GSK2646264 also inhibits several other kinases, including LCK, LRRK2, GSK3β, JAK2, VEGFR2, Aurora B, and Aurora A, with pIC50 values of 5.4, 5.4, 5.3, 5, 4.5, <4.6 and <4.3, respectively. Notably, GSK2646264 demonstrates skin penetrability, reaching both the epidermis and dermis [1].
T38626	GSK143
	GSK143 is a potent orally active and highly selective inhibitor of spleen tyrosine kinase (SYK) with a pIC 50 of 7.5. Furthermore, GSK143 effectively inhibits phosphorylated Erk (pErk) with a pIC 50 value of 7.1. In addition, GSK143 exhibits promising anti-inflammatory properties by reducing inflammation and impeding the recruitment of immune cells in the intestinal muscularis of mice.
T78641	ER-27319	Syk	Angiogenesis; Tyrosine Kinase/Adaptors
	ER-27319为吖啶酮衍生物，高效选择性抑制SYK，阻断其酪氨酸磷酸化和活性。本化合物阻止抗原刺激下人及大鼠肥大细胞释放过敏介质，IC50约为10 μM，适用于过敏性疾病研究。
T70377	BAY 61-3606 HCl
	BAY 61-3606 HCl is a cell-permeable, reversible inhibitor of spleen tyrosine kinase. BAY 61-3606 HCl can inhibit degranulation and block cytokine release from mast cells. Oral administration of BAY 61-3606 to rats was shown to suppress antigen-induced passive cutaneous anaphylactic reaction, bronchoconstriction, and bronchial edema. It can also sensitize MCF-7 breast cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis by inhibiting Cdk9. This compound has been used i...

化合物

TAK-659 hydrochloride

Cat.No: T4209

Synonym: TAK-659

Target: VEGFR, FLT, Tyrosine Kinases, JAK, Syk

Cevidoplenib dimesylate

Cat.No: T39437

Target: Syk

Cat.No: T16776

Target: Syk

Cat.No: T14331

Synonym: ASN-002

Target: JAK, Syk

Cat.No: T6594

Target: Syk, Src, p97

Cat.No: T11824LL

Synonym: GS-9876

Target: Syk

Cat.No: T6101

Synonym: GS-9973

Target: Syk

Cat.No: T6115

Synonym: R788,福他替尼

Target: FLT, Syk, Monoamine Transporter, Adenosine Receptor

Cat.No: T6174

Synonym: R-406 besylate

Target: Apoptosis, FLT, Syk

Cat.No: T2467

Synonym: R406 (free base)

Target: Apoptosis, FLT, Syk

Syk Inhibitor II

Cat.No: T4348

Target: 5-HT Receptor, Syk

Cat.No: T2487

Synonym: PRT2070,赛度替尼,PRT062070

Target: Tyrosine Kinases, JAK, Syk

Cat.No: T3185

Synonym: (E)-Elafibranor

Target: Syk

Cat.No: T6957

Synonym: P142-76,PRT318,PRT-060318 2HCl

Target: Syk

Fostamatinib Disodium

Cat.No: T2605

Synonym: Tamatinib Fosdium,福他替尼二钠盐,R788(Disodium),R788 Disodium,R788 (Fostamatinib) Disodium

Target: FLT, Syk

BAY 61-3606 dihydrochloride

Cat.No: T6776

Synonym: BAY 61-3606,BAY-61-3606 dihydrochloride

Target: Apoptosis, Syk

PRT062607 hydrochloride

Cat.No: T2696

Synonym: PRT062607 (P505-15, BIIB057) HCl,P505-15 Hydrochloride

Target: MLK, Syk, Src

Cat.No: T4263

Synonym: 2-[[7-(3,4-二甲氧基苯基)咪唑并[1,2-C]嘧啶-5-基]氨基]-3-吡啶甲酰胺,Syk inhibitor IV

Target: Apoptosis, Syk

Cerdulatinib hydrochloride

Cat.No: T6104

Synonym: Cerdulatinib,PRT2070,PRT062070 hydrochloride,PRT062070,PRT2070 hydrochloride

Target: MLK, c-Fms, Tyrosine Kinases, Hippo pathway, JAK, Syk

Cat.No: T28281

Synonym: OXSI 2,Syk Inhibitor

Target: Syk

Cevidoplenib dimesylate hydrochloride

Cat.No: T9789

Target: Syk

Cat.No: T9659

Synonym: 3-(2-(3-(Morpholinomethyl)phenyl)thieno[3,2-b]pyridin-7-ylamino)phenol

Target: Discoidin Domain Receptor (DDR)

P505-15 Acetate

Cat.No: T24584

Synonym: PRT 062607 Acetate,P505 15 Acetate,PRT-062607 Acetate,PRT062607 Acetate,P50515 Acetate

Target: Tyrosinase

Syk Inhibitor II dihydrochloride

Cat.No: T4391

Synonym: Syk Inhibitor II (hydrochloride)

Target: Others, Tyrosine Kinases, Syk, PKC, BTK

Syk Inhibitor II hydrochloride

Cat.No: T9543

Target: Others

Cat.No: T70931

Cat.No: T21062

Synonym: TAK 659,TAK659

Cat.No: T37602

Cat.No: T70994

Cat.No: T78943

Target: Syk

GSK SYK inhibitor

Cat.No: T70930

GSK143 dihydrochloride

Cat.No: T39874

Cat.No: T61527

Cat.No: T38626

Cat.No: T78641

Target: Syk

BAY 61-3606 HCl

Cat.No: T70377

Cat. No.	Product Name	Target	Signaling Pathways
T0610	Piceatannol 白皮杉醇,trans-Piceatannol,Astringenin	Apoptosis; Serine/threonin kinase; PKA; Syk; PKC; Autophagy	Angiogenesis; Apoptosis; Autophagy; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; Metabolism; Tyrosine Kinase/Adaptors
	Piceatannol (Astringenin) 是一种Syk 抑制剂，可降低由 TNF 诱导的 iNOS 表达，可研究急性肺损伤。它是存在于各种水果和蔬菜中天然存在的多酚二苯乙烯，可诱导细胞自噬和凋亡，具有抗癌和抗炎特性。

天然产物

Cat.No: T0610

Synonym: 白皮杉醇,trans-Piceatannol,Astringenin

Target: Apoptosis, Serine/threonin kinase, PKA, Syk, PKC, Autophagy

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼